Search

Search Results
Results 191 - 200 of 952 for allergy
  • Drug - 26 Nov 2024
    Consumer Medicine Information (CMI) about DBL Tobramycin Injection (tobramycin) intended for persons living in Australia.
  • Drug - 26 Nov 2024
    Consumer Medicine Information (CMI) about Tobramycin PF (tobramycin) intended for persons living in Australia.
  • Drug - 9 Oct 2024
    Consumer Medicine Information (CMI) about Lorazepam Viatris (lorazepam) intended for persons living in Australia.
  • Drug - 12 Aug 2024
    Consumer Medicine Information (CMI) about Pacrolim (Tacrolimus) intended for persons living in Australia.
  • Drug - 29 Jul 2024
    Consumer Medicine Information (CMI) about Alphapress (hydralazine hydrochloride) intended for persons living in Australia.
  • Drug - 1 Jul 2024
    Consumer Medicine Information (CMI) about Trajenta (linagliptin) intended for persons living in Australia.
  • Drug - 31 May 2024
    Consumer Medicine Information (CMI) about NovoSeven RT (eptacog alfa Recombinant coagulation factor VIIa) intended for persons living in Australia.
  • Drug - 30 May 2024
    Consumer Medicine Information (CMI) about Vaqta (Hepatitis A vaccine, Inactivated) intended for persons living in Australia.
  • Drug - 30 Apr 2024
    Consumer Medicine Information (CMI) about DBL Cisplatin Injection (cisplatin) intended for persons living in Australia.
  • Drug - 17 Apr 2024
    Consumer Medicine Information (CMI) about Fonat (alendronate sodium) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.